Epigallocatechin gallate accelerates healing of indomethacin-induced stomach ulcers in mice

Pharmacological Reports

Volumn 63, Issue 2, 2011, Pages 527-536

  Adhikary, Biplab ^a   Yadav, Sudhir K ^a   Bandyopadhyay, Sandip K ^a   Chattopadhyay, Subrata ^b  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Antioxidant; COX; Gastric ulcer; Mucin; Prostaglandin

Indexed keywords

EPIGALLOCATECHIN GALLATE; INDOMETACIN; OMEPRAZOLE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG STRUCTURE; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROSTAGLANDIN SYNTHESIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; STOMACH ULCER; TREATMENT DURATION; TREATMENT RESPONSE; ULCER HEALING;

EID: 79955934065     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70519-9     Document Type: Article

References (37)

1. Avila JR, de la Lastra CA, Martin MJ, Motilva V, Luque I, Delgado D, Esteban J, Herrerias J: Role of endogenous sulphydryls and neutrophil infiltration in the pathogenesis of gastric mucosal injury induced by piroxicam in rats. Inflamm Res, 1996, 45, 83-88. (Pubitemid 26064409)
2. Banerjee D, Maity B, Bauri AK, Bandyopadhyay SK, Chattopadhyay S: Gastroprotective property of Myristica malabarica against indomethacin-induced stomach ulceration: A mechanistic exploration. J Pharm Pharmacol, 2007, 59, 1555-1565.
3. Bertrand V, Guessous F, Le Roy AL, Viossat B, Fessi H, El Abbouyi A, Giroud JP, Roch-Arveiller M: Copper-indomethacinate associated with zwitterionic phospholipids prevents enteropathy in rats: effect on inducible no synthase. Dig Dis Sci, 1999, 44, 991-999. (Pubitemid 29205612)
4. Brown AL, Lane J, Coverly J, Stocks J, Jackson S, Stephen A, Bluck L et al.: Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr, 2009, 101, 886-894.
5. +-ATPase and alcohol dehydrogenase following ethanol-induced injury in rats. Dig Dis Sci, 1999, 44, 1417-1422.
6. Calixto JB, Campos MM, Otuki MF, Santos AR: Antiinflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med, 2004, 70, 93-103. (Pubitemid 38299768)
7. Chan FKL: Primer: managing NSAID-induced ulcer complications - balancing gastrointestinal and cardiovascular risks. Nat Clin Pract Gastroenterol Hepatol, 2006, 3, 563-573.
8. Devika PT, Prince PSM: Protective effect of (-)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: A histopathological study. Biomed Pharmacother, 2008, 62, 701-708.
9. Dokmeci D, Akpolat M, Aydogu N, Doganay L, Turan FN: L-Carnitine inhibits ethanol-induced gastric mucosal injury in rats. Pharmacol Rep, 2005, 57, 481-488. (Pubitemid 41288689)
10. Ghiselli A, Serafini M, Natella F, Scaccini C: Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med, 2000, 29, 1106-1114.
11. Goldstein JL, Johanson JF, Hawkey CJ, Suchower LJ, Brown KA: Clinical trial: Healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - A randomized study comparing ranitidine with esomeprazole. Aliment Pharmacol Ther, 2007, 26, 1101-1111. (Pubitemid 47480959)
12. Gryglewski RJ, Szczeklik A, Wandzilak M: The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl- methionylleucyl-phenylalanine. Biochem Pharmacol, 1987, 36, 4209-4213. (Pubitemid 18016171)
13. Halter F, Schamassman A, Peskar BM, Tarnawski AS: Cyclooxygenase-2 implications on maintenance of gastric mucosal integrity and ulcer healing: controversies and perspectives. Gut, 2001, 49, 443-453. (Pubitemid 32802583)
14. Hamaishi K, Kojima R, Ito M: Anti-ulcer effect of tea catechin in rats. Tea catechin at oral doses of 100 and 200 mg/kg was ineffective in decreasing either the volume or total acid output. Biol Pharm Bull, 2006, 29, 2206-2213.
15. Hassan S, Kinoshita Y, Min D, Nakata H, Kishi K, Matsushima Y, Asahara M et al.: Presence of prostaglandin EP4 receptor gene expression in a rat gastric mucosal cell line. Digestion, 1996, 57, 196-200. (Pubitemid 26129068)
16. Hawkins C, Hanks GW: The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs. A review of the literature. J Pain Symptom Manage, 2000, 20, 140-151.
17. Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS: Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med, 1999, 5, 1418-1423.
18. Lanas A, Perez-Aisa MA, Feu F, Ponce J: A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with non-steroidal anti-inflammatory drug use. Am J Gastroenterol, 2005, 100, 1685-1693. (Pubitemid 41648418)
19. Lee KM, Yeo M, Choue JS, Jin JH, Park SJ, Cheong JY, Lee KJ et al.: Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori-induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling. Helicobacter, 2004, 9, 632-642.
20. Levenstein S: Stress and peptic ulcer: life beyond Helicobacter. BMJ, 1998, 316, 538-541.
21. Miller TA: Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol, 1983, 245, G601-G623.
22. Miura T, Muraoka S, Fujimoto Y: Lipid peroxidation induced by indomethacin with horseradish peroxidase and hydrogen peroxide: involvement of indomethacin radicals. Biochem Pharmacol, 2002, 63, 2069-2074.
23. Naito Y, Yoshikawa T, Matsuyama K, Yagi N, Arai M, Nakamura Y, Nishimura S et al.: Effects of oxygen radical scavengers on the quality of gastric ulcer healing in rats. J Clin Gastroenterol, 1995, 21, Suppl 1, S82-S86. (Pubitemid 26001723)
24. Newaz MA, Nawal NNA: Effect of -tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. Am J Hypertens, 1998, 11, 1480-1485. (Pubitemid 29030314)
25. Rainsford KD: The effects of aspirin and other nonsteroid antiinflammatory analgesic drugs on gastrointestinal mucus glycoprotein biosynthesis in vivo: relationship to ulcerogenic actions. Biochem Pharmacol, 1978, 27, 877-885.
26. Sedlak J, Lindsay RH: Estimation of total protein-bound, and non-protein sulphydryl groups in tissue with Ellman's reagent. Anal Biochem, 1968, 25, 192-205.
27. Swarnakar S, Ganguly K, Kundu P, Banerjee A, Maity P, Sharma AV: Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem, 2005, 280, 9409-9415. (Pubitemid 40409634)
28. Tabor CW, Tabor H: Polyamines. Annu Rev Biochem, 1984, 53, 749-790. (Pubitemid 14059150)
29. Takeuchi Y, Kitano S, Bandoh T, Matsumoto T, Baatar D, Kai S: Acceleration of gastric ulcer healing by omeprazole in portal hypertensive rats. Is its action mediated by gastrin release and the stimulation of epithelial proliferation? Eur Surg Res, 2003, 35, 75-80.
30. Tariq M, Al Moutaery A: Menadione protects gastric mucosa against ethanol-induced ulcers. Exp Toxicol Pathol, 2005, 56, 393-399. (Pubitemid 40585801)
31. Tarnawski AS, Jones MK: Inhibition of angiogenesis by NSAIDs: molecular mechanism and clinical applications. J Mol Med, 2003, 81, 627-636. (Pubitemid 37357677)
32. Varilek GW, Yang F, Lee EY, deVilliers WJ, Zhong J, Oz HS, Westberry KF, McClain CJ: Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr, 2001, 131, 2034-2039. (Pubitemid 32661076)
33. Wallace JL: Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology, 1997, 112, 1000-1016.
34. Wallace JL: Recent advances in gastric ulcer therapeutics. Curr Opin Pharmacol, 2005, 5, 573-577.
35. Yadav SK, Adhikary B, Maity B, Bandyopadhyay SK, Chattopadhyay S: The gastric ulcer-healing action of allylpyrocatechol is mediated by modulation of arginase metabolism and shift of cytokine balance. Eur J Pharmacol, 2009, 614, 106-113.
36. Yoshikawa T, Naito Y, Kishi A, Tomii T, Kaneko T, Iinuma S, Ichikawa H et al.: Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut, 1993, 34, 732-737. (Pubitemid 23185094)
37. Zurier RB, Quagliata F: Effect of prostaglandin E1 on adjuvant arthritis. Nature, 1971, 234, 304-305.